Search Results

Displaying Results 351-375 of 3785 "'PHD'"

Jul 31, 2026, 15:31 ET Research Team Co-Led by Rosalind Franklin University Awarded $3.4 Million Grant to Address Bone-Stress Injuries in Military Recruits

incentive to improve early diagnosis and risk stratification.Shawn D. Flanagan, PhD, director of the Human Performance Laboratory at RFU's Center for Lower Extremity Ambulatory Research (CLEAR), and Chris Connaboy, PhD, Batten Endowed Professor of Health Sciences at Old Dominion University, are studying

More news about: Rosalind Franklin University of Medicine and Science


Jul 31, 2026, 13:03 ET Advancing Precision Oncology with Biomarker-driven Strategies and Digital Data Solutions, Upcoming Webinar Hosted by Xtalks

precision oncology strategies can strengthen biomarker-driven patient identification, trial execution and evidence generation.Join Mark Yates, MD, PhD, Director of RWE Strategy and RWD Solutions,

More news about: Xtalks


Jul 31, 2026, 10:18 ET Robo.ai Appoints Dr. Jasem Al-Mansory as Chief Executive Officer of Its Subsidiary Alif Holding

earlier as Director of the Inspection Department in the Office of the General Inspector and as Head of Administrative and Financial Affairs. He holds a PhD in Human Resource Management from the University of Southampton, United Kingdom, along with a Master's in Police Sciences and a Bachelor's in Business

More news about: Robo.ai Inc.; Alif Holding


Jul 31, 2026, 10:00 ET Cincinnati Children's Receives $38.4 Million NIH Grant Renewal to Expand Landmark Congenital Heart Disease Genomics Program

Nicholas Ollberding, PhD, contact principal investigator for the coordinating center at Cincinnati Children's. "By connecting genomic information with clinical follow-up, patient-reported

More news about: Cincinnati Children's Hospital Medical Center


Jul 31, 2026, 09:55 ET Robo.ai Appoints Dr. Jasem Al-Mansory as Chief Executive Officer of Its Subsidiary Alif Holding

earlier as Director of the Inspection Department in the Office of the General Inspector and as Head of Administrative and Financial Affairs. He holds a PhD in Human Resource Management from the University of Southampton, United Kingdom, along with a Master's in Police Sciences and a Bachelor's in Business

More news about: Robo.ai Inc.; Alif Holding


Jul 31, 2026, 09:30 ET CU Anschutz Physicians Recognized Among Colorado's Top Doctors for 2026

testament to what makes CU Anschutz unique: exceptional physicians working together to solve medicine's toughest challenges," said John H. Sampson, MD, PhD, MHSc, MBA, dean of the CU Anschutz School of Medicine. "From routine care to the most complex cases, our teams are transforming discoveries into better

More news about: University of Colorado Anschutz


Jul 31, 2026, 09:13 ET Cornea Transplant Specialist Mohammad Dastjerdi, MD, Joins NYU Langone Eye Center

Kathryn A. Colby, MD, PhD, the Elisabeth J. Cohen, MD, Professor of Ophthalmology and chair of the Department of Ophthalmology. "His expertise and collaborative, team-based

More news about: NYU Langone Health


Jul 31, 2026, 08:30 ET Invideo Agent One ranks #1 in Physion-Arc 1.0 Benchmark

generative video, which it describes as world critics for world models. The lab is led by CEO Evelyn Qin Zhang, previously at AWS AI Labs with an MIT PhD in physics-based simulation and machine learning, and CTO Bing Shuai, formerly a principal scientist at AWS AI. Physion-Arc 1.0 is its third benchmark

More news about: invideo


Jul 31, 2026, 07:00 ET CREATE Medicines Expands Targeted In Vivo CAR Platform Through Strategic Research Collaboration and Exclusive License Agreement with Monash University

already clinically validated and targeted mRNA platform, we can further apply that precision across an even broader range of targets," said Daniel Getts, PhD, Founder and Chief Executive Officer of CREATE Medicines. "Together, we will unlock a new generation of programmable medicines that reach more patients

More news about: CREATE Medicines, Inc.


Jul 31, 2026, 05:17 ET MOYOM Advances European Regenerative Aesthetics Through APHRANEL® EU MDR Certification and Strategic Scientific Collaboration with Expert2Expert

international scientific collaboration to strengthen APHRANEL®'s medical credibility across Europe.Patrice Delobel, PhD, European Medical and Marketing Director at MOYOM, said:"When I decided to join MOYOM, my ambition was never simply to oversee

More news about: Aphranel®


Jul 31, 2026, 04:53 ET MOYOM Advances European Regenerative Aesthetics Through APHRANEL® EU MDR Certification and Strategic Scientific Collaboration with Expert2Expert

international scientific collaboration to strengthen APHRANEL®'s medical credibility across Europe.Patrice Delobel, PhD, European Medical and Marketing Director at MOYOM, said:"When I decided to join MOYOM, my ambition was never simply to oversee

More news about: Aphranel®


Jul 31, 2026, 03:42 ET Robo.ai Appoints Dr. Jasem Al-Mansory as Chief Executive Officer of Its Subsidiary Alif Holding

earlier as Director of the Inspection Department in the Office of the General Inspector and as Head of Administrative and Financial Affairs. He holds a PhD in Human Resource Management from the University of Southampton, United Kingdom, along with a Master's in Police Sciences and a Bachelor's in Business

More news about: Robo.ai Inc.; Alif Holding


Jul 30, 2026, 16:05 ET Karyopharm Announces Topline Results from Phase 3 XPORT-EC-042 Trial in Endometrial Cancer

tens of thousands of endometrial cancer patients worldwide. We are deeply committed to further investigating these data," said Reshma Rangwala, MD, PhD, Chief Medical Officer and Head of Research at Karyopharm. "I would like to thank all of the patients, their families and the clinical trial investigators

More news about: Karyopharm Therapeutics Inc.


Jul 30, 2026, 09:00 ET Nominations Open for 14th Annual International Harrington Prize for Innovation in Medicine

treatment.2024: Arlene H. Sharpe, MD, PhD, Harvard University, for her breakthrough discoveries in immune regulation, which have established foundational principles in immunology and led to new cancer therapies.2023: Jointly awarded to Jean Bennett, MD, PhD, and Albert M. Maguire, MD, both

More news about: Harrington Discovery Institute


Jul 30, 2026, 09:00 ET FSHD Industry Collaborative Expands with Four Biopharma Sponsors and Reports Rapid Advances Across Multiple Muscular Dystrophy Research Programs

model of how to integrate existing data sources in the rare disease space to accelerate development of therapies for patients," said John Staropoli, MD, PhD, Vice President of Clinical Research at Scholar Rock.A Growing Coalition for FSHDRather than supporting a single research focus,

More news about: FSHD Society


Jul 30, 2026, 09:00 ET Jefferson Announces New Appointments to its Board of Trustees

(which includes Thomas Jefferson University, Jefferson Health, and Jefferson Health Plans) announced today the appointment of Anthony P. Monaco, MD, PhD, and Elizabeth Bierbower to its enterprise (TJU) Board of Trustees.

More news about: Thomas Jefferson University


Jul 30, 2026, 09:00 ET The Menta Education Group Names Inaugural Chief Information Officer and Chief Human Resources Officer, Following Executive Search Led by Stanton Chase

privileged to partner with Menta's leadership team on two searches that will shape the organization for years to come," said Meredith Harper Bonham, PhD, Managing Director at Stanton Chase. "These leaders arrive at a pivotal time for the organization, and bring deep functional expertise with a genuine

More news about: Stanton Chase


Jul 30, 2026, 08:57 ET Chandigarh University's Biotechnology & Pharmacy Students Secure 178 Placements with Leading Pharmaceutical and Biotechnology Companies

Two design patents have been granted, while three patents have been filed. Several students have also qualified CSIR-NET JRF and secured admission to PhD programmes at premier institutions including the Indian Institute of Science (IISc), Bengaluru, IIT Delhi, IIT Roorkee and IIIM Jammu.The department's

More news about: Chandigarh University


Jul 30, 2026, 08:32 ET New Clinical Research Presented at NUTRITION 2026 Shows Superbrewed Food's Postbiotic Cultured Protein Matches Whey in Muscle-Building Response

a postbiotic protein against whey and pea protein using a novel intracellular tracer method developed by lead investigator Nicolaas E.P. Deutz, MD, PhD, and published in Clinical Nutrition.Findings were presented in an oral session on the afternoon of July 26 at NUTRITION

More news about: Superbrewed Food Inc.


Jul 30, 2026, 08:30 ET Accelerating Custom Spatial Proteomic Panel Development for New Biological Insights, Upcoming Webinar Hosted by Xtalks

Quanterix®, Antoinette Ronquillo, MS, Senior Field Application Scientist; and Clemens Duerrschmid, PhD, Senior Manager, Field Applications, for the live webinar on Tuesday, August 25, 2026, at 11am EDT (5pm CEST / EU-Central).For more information,

More news about: Xtalks


Jul 30, 2026, 08:00 ET Spark Biomedical to Present Acute Stress Reaction, Anxiety, and Sleep Data at 2026 Military Health System Research Symposium

neurostimulation (tAN®) platform for cognitive performance and sleep in operational and military health contexts. Michael Darrow, PhD, Spark's Director of Research Innovations, will present "Enhancing Warfighter Readiness with Wearable Auricular Neurostimulation: Development

More news about: Spark Biomedical


Jul 30, 2026, 08:00 ET TSC Alliance and Apertura Gene Therapy Complete Preclinical Pilot Study Evaluating AAV Gene Therapy Approach Designed for TSC1

broad distribution to the brain and other organs."We are encouraged by the initial findings from the preclinical pilot study," said Dean Aguiar, PhD, TSC Alliance Executive Vice President, Translational Research. "The results generated to date support further preclinical testing to evaluate the approach

More news about: TSC Alliance


Jul 30, 2026, 08:00 ET ProtaGene, CGT Announces CAP & CLIA Approval for ISA Testing

our role as a trusted biopharma partner, advancing safe therapies through reliable, high-quality analytics" added Michael Stump, PhD, President at ProtaGene US. About ProtaGeneProtaGene is a world-leading CRO partner for the biopharmaceutical and cell and gene

More news about: Protagene, US Inc


Jul 30, 2026, 07:30 ET Bacterial Vaginosis Linked to Increased STI Co-Infection, Finds National Study of 1.5 Million Women from Quest Diagnostics

increased STI risk in women with BV, but with the advantage of a much larger data set from which to draw conclusions," said Elizabeth M. Marlowe, MS, PhD, Executive Director, Infectious Disease, Quest Diagnostics. "This large study underscores the value of comprehensive molecular testing when clinically

More news about: Quest Diagnostics


Jul 30, 2026, 07:00 ET CREATE Medicines Receives Approval to Initiate First-in-Human Phase 1/2 Clinical Trial of In Vivo CAR-T Candidate CRT-402 for Autoimmune Diseases

in vivo CAR therapies directly in patients, and CRT-402 represents a natural extension of that platform into autoimmune disease," said Daniel Getts, PhD, Chief Executive Officer and Co-founder of CREATE Medicines. "The preclinical data supporting CRT-402 are highly encouraging, and we are grateful to

More news about: CREATE Medicines, Inc.


Making a selection with these dropdown will cause content on this page to change. News search result will update as each option is selected.